WHAT IS ALREADY KNOWN ON THIS TOPIC?
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
Rituximab is superior to azathioprine for the prevention of major relapse following cyclophosphamide induction therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV).